Directory
>
Andy Stadheim
Andy Stadheim
Vice President | Entrada Therapeutics
Boston, Massachusetts, United States
Andy Stadheim
Summary
Andy Stadheim is a seasoned biotechnology executive currently serving as Vice President at Entrada Therapeutics in Boston. With extensive experience spanning over two decades in the biotech and pharmaceutical industries, he has a strong background in analytical chemistry, biochemistry, and drug development. Andy has demonstrated exceptional leadership in managing cross-functional teams and fostering research collaborations. His educational credentials include a PhD in Pharmacology and an MBA, equipping him with both scientific and business acumen. He has previously held senior roles at notable companies like Novo Nordisk and Merck, where he contributed to significant advancements in biologics and oligonucleotide therapies. Passionate about innovation in life sciences, Andy is committed to leveraging his expertise to drive impactful healthcare solutions. His journey reflects a blend of technical proficiency and strategic insight, making him a valuable asset in the biotechnology landscape.
Andy Stadheim
Work Experience
Vice President at
Entrada Therapeutics
January 2021 - Present
Head of Product Development / Antibody Discovery at
Entrada Therapeutics
January 2020 - January 2021
Senior Manager, Quality Control at
Novo Nordisk
January 2017 - January 2020
Director at
Celdara Medical
January 2016 - January 2017
Director- Molecular Discovery at
Merck
January 2012 - January 2016
Director Strain Development and High Throughput Screening at
GlycoFi
August 2008 - January 2012
Associate Director High Throughput Screening at
GlycoFi
February 2008 - August 2008
Associate Director Analytical Development at
GlycoFi
March 2006 - February 2008
Senior Scientist at
GlycoFi
August 2005 - February 2006
Scientist II at
GlycoFi
December 2003 - August 2005
Scientist I at
GlycoFi
December 2002 - December 2003
Postdoc at
GlycoFi
September 2002 - December 2002
Andy Stadheim
Education
Harvard Business School Executive Education
January 2016 - January 2016
Dartmouth College, Postdoc
January 1999 - January 2002
January 1994 - January 1998
Virginia Tech MBA, Bs
January 1991 - January 1994
January 1990 - January 1991
Frequently Asked Questions about Andy Stadheim
What is Andy Stadheim email address?
Andy Stadheim's primary email address is *********@entradatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Andy Stadheim work for?
Andy Stadheim is a Vice President at Entrada Therapeutics, a company specializing in Commercial physical research.
Where Andy Stadheim graduated from?
Andy Stadheim holds a degree in Merck Emerging Leaders Program from Harvard Business School Executive Education.
How can I directly contact Andy Stadheim?
To contact Andy Stadheim directly, you can use the email address *********@entradatx.com. Complete contact information is available upon registration with Muraena.
Who is Andy Stadheim?
Andy Stadheim is a seasoned biotechnology executive currently serving as Vice President at Entrada Therapeutics in Boston. With extensive experience spanning over two decades in the biotech and pharmaceutical industries, he has a strong background in analytical chemistry, biochemistry, and drug development. Andy has demonstrated exceptional leadership in managing cross-functional teams and fostering research collaborations. His educational credentials include a PhD in Pharmacology and an MBA, equipping him with both scientific and business acumen. He has previously held senior roles at notable companies like Novo Nordisk and Merck, where he contributed to significant advancements in biologics and oligonucleotide therapies. Passionate about innovation in life sciences, Andy is committed to leveraging his expertise to drive impactful healthcare solutions. His journey reflects a blend of technical proficiency and strategic insight, making him a valuable asset in the biotechnology landscape.
Andy`s contact details
*********@entradatx.com
Colleagues
Executive Director, FP&A
Executive Director
Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics
Chief Financial Officer and Treasurer
Board Member
Co-Founder & Vice President, Discovery Research
Vice President | Head of CMC
President Research And Development at Entrada Therapeutics
President and Chief Operating Officer
VP, Program Governance & Portfolio Management